Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structure-activity optimization of ryanodine receptor modulators for the treatment of catecholaminergic polymorphic ventricular tachycardia

Heart Rhythm(2024)10.1016/j.hrthm.2024.09.062Source: DataRank Database

Structure-activity optimization of ryanodine receptor modulators for the treatment of catecholaminergic polymorphic ventricular tachycardia is a research paper published in Heart Rhythm (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.89)OA: closedTopics (39)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Martha Sibrian‐Vazquez,José Alberto Navarro‐García ORCID,Yuriana Aguilar-Sánchez ORCID,Mara R Turkieltaub-Paredes,Satadru K. Lahiri ORCID

Live enrichment

PubMed:39366435 OpenAlex:https://openalex.org/W4403054222

American Heart Association

Grant: 837586

National Institutes of Health

Grant: R01-HL147108

National Institutes of Health

Grant: R01-HL160992

National Institutes of Health

Grant: R01-HL153350

National Institutes of Health

Grant: R44-HL114206

National Institutes of Health

Grant: F30-HL156660

National Institutes of Health

Grant: K23-HL136932

National Institutes of Health

Grant: R01-HL089598

National Institutes of Health

Grant: T32-HL139430

Baylor College of Medicine

FWCI

0.89

Citation Percentile

0.8%

Citation Trend

2025

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S1547527124033939?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1547527124033939?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.hrthm.2024.09.062

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39366435

Fields of Study

Cardiac electrophysiology and arrhythmiasCardiac Arrhythmias and TreatmentsIon channel regulation and functionAnimalsTachycardia, VentricularRyanodine Receptor Calcium Release ChannelMicePolymorphic Catecholaminergic Ventricular TachycardiaStructure-Activity RelationshipMyocytes, CardiacDisease Models, AnimalTetracaineElectrocardiographyMale

MeSH Terms

Polymorphic Catecholaminergic Ventricular TachycardiaAnimalsDisease Models, AnimalElectrocardiographyMaleStructure-Activity RelationshipTetracaineTachycardia, VentricularRyanodine Receptor Calcium Release ChannelMyocytes, CardiacMice

Keywords

Catecholaminergic polymorphic ventricular tachycardiaMedicineRyanodine receptorInternal medicineCardiologyVentricular tachycardiaRyanodine receptor 2CatecholaminergicPharmacologyReceptorDopamineStructure-activity relationshipTetracaineRyr2

Sustainable Development Goals

SDG 0: Good health and well-being

Structure-activity optimization of ryanodine receptor modulators for the treatment of catecholaminergic polymorphic ventricular tachycardia

FAIR Checklist

Authors (11)

Funding (10 grants)

Impact

Open Access

Topics